Multiple Endocrine Neoplasia Type 1
"Multiple Endocrine Neoplasia Type 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13).
Descriptor ID |
D018761
|
MeSH Number(s) |
C04.588.322.400.500 C04.651.600.500 C04.700.630.500 C16.320.700.630.500 C19.344.400.500
|
Concept/Terms |
Multiple Endocrine Neoplasia Type 1- Multiple Endocrine Neoplasia Type 1
- Multiple Endocrine Neoplasia Type I
- Neoplasms, Multiple Endocrine Type I
- Multiple Endocrine Neoplasms Type 1
- Neoplasia, Multiple Endocrine Type 1
- Neoplasms, Multiple Endocrine Type 1
- Wermer Syndrome
|
Below are MeSH descriptors whose meaning is more general than "Multiple Endocrine Neoplasia Type 1".
Below are MeSH descriptors whose meaning is more specific than "Multiple Endocrine Neoplasia Type 1".
This graph shows the total number of publications written about "Multiple Endocrine Neoplasia Type 1" by people in this website by year, and whether "Multiple Endocrine Neoplasia Type 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2007 | 1 | 1 | 2 |
2012 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2020 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Multiple Endocrine Neoplasia Type 1" by people in Profiles.
-
Tirosh A, Killian JK, Petersen D, Zhu YJ, Walker RL, Blau JE, Nilubol N, Patel D, Agarwal SK, Weinstein LS, Meltzer P, Kebebew E. Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition. J Clin Endocrinol Metab. 2020 10 01; 105(10).
-
Cohen-Cohen S, Brown DA, Himes BT, Wheeler LP, Ruff MW, Major BT, Singh Ospina NM, Atkinson JLD, Meyer FB, Bancos I, Young WF, Van Gompel JJ. Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience. J Neurosurg. 2020 Apr 03; 134(3):1132-1138.
-
Singh Ospina N, Thompson GB, C Nichols F, Cassivi SD, Young WF. Thymic and Bronchial Carcinoid Tumors in Multiple Endocrine Neoplasia Type 1: The Mayo Clinic Experience from 1977 to 2013. Horm Cancer. 2015 Dec; 6(5-6):247-53.
-
Lewis MA, Thompson GB, Young WF. Preoperative assessment of the pancreas in multiple endocrine neoplasia type 1. World J Surg. 2012 Jun; 36(6):1375-81.
-
You YN, Thompson GB, Young WF, Larson D, Farley DR, Richards M, Grant CS. Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: Operative outcomes, long-term function, and quality of life. Surgery. 2007 Dec; 142(6):829-36; discussion 836.e1.
-
Ippolito G, Palazzo FF, Sebag F, Henry JF. Long-term follow-up after parathyroidectomy for radiation-induced hyperparathyroidism. Surgery. 2007 Dec; 142(6):819-22; discussion 822.e1.
-
Benito M, Asa SL, Livolsi VA, West VA, Snyder PJ. Gonadotroph tumor associated with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2005 Jan; 90(1):570-4.
-
Greenberg LW, Badosa F, Niakosari A, Schneider A, Zaeri N, Schindler AM. Clinicopathologic exercise: hypoglycemia in a young woman with amenorrhea. J Pediatr. 2000 Jun; 136(6):818-22.
-
Long PP, Hruban RH, Lo R, Yeo CJ, Morsberger LA, Griffin CA. Chromosome analysis of nine endocrine neoplasms of the pancreas. Cancer Genet Cytogenet. 1994 Oct; 77(1):55-9.